Semaglutide and teduglutide reduce immune-driven gut injury in mice
Researchers found that gut-derived GLP-1 and GLP-2 signaling helped protect mice against T cell-induced intestinal injury, with GLP-1R primarily regulating inflammation and GLP-2R supporting intestinal repair. Semaglutide and teduglutide, administered separately or together, reduced acute intestinal damage in mice lacking intestinal proglucagon, suggesting potential avenues for investigating…
Read original article on The Medical News →Related news
-
Canada's youngest generation is off to a healthy start, but screen time is a challenge
United Kingdom
-
Beef can fit into healthy diets, but what about its environmental cost?
United Kingdom
-
AAO: Sequential nonarteritic anterior ischemic optic neuropathy occurs earlier with GLP-1 receptor agonist exposure
United Kingdom
-
Eye tracking could help virtual reality pain therapy adapt to individual needs
United Kingdom
-
Attacks on water systems are attacks on health, say experts
United Kingdom
-
Use green transition funds to achieve health for all, suggest experts
United Kingdom
-
Is all screen time bad for children? Maybe not, new review suggests
United Kingdom
-
One tooth, six clues: How a single tooth can help in identifying deceased persons
United Kingdom